Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | MRNA | BMY | AMGN | GILD |
| Company | Akcea Therapeutics Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 18.15 | 67.60 | 49.29 | 335.15 | 83.26 |
| High | 18.17 | 67.91 | 49.53 | 338.97 | 83.99 |
| Low | 18.13 | 64.70 | 49.00 | 334.27 | 82.75 |
| Last | 18.17 | 65.69 | 49.41 | 337.38 | 83.94 |
| Change | +0.03 | -2.33 | +0.39 | +1.43 | +0.04 |
| % Change | +0.17% | -3.43% | +0.80% | +0.43% | +0.05% |
| Volume | 815,300 | 12,418,200 | 27,106,501 | 4,067,800 | 24,925,701 |
| 20-Day Average Volume | 661,490 | 5,880,490 | 9,468,090 | 1,855,480 | 7,644,680 |
| Previous Close | 18.14 | 68.02 | 49.02 | 335.95 | 83.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 74.31 | 49.18 | 330.23 | 80.47 |
| 20-Day Raw Stochastic | 70.59% | 7.83% | 60.24% | 91.90% | 89.42% |
| 20-Day Relative Strength | 73.10% | 30.77% | 55.67% | 58.76% | 71.95% |
| Weighted Alpha | -23.90 | -38.81 | -10.22 | +27.84 | +18.32 |
| Today's Opinion | 72% Buy | 88% Sell | 72% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 64% Buy | 88% Sell | 56% Buy | 96% Buy | 88% Buy |
| Last Month's Opinion | 8% Buy | 56% Sell | 40% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | -3.79% since 09/13/24 | +0.57% since 09/13/24 | +1.48% since 09/13/24 | +1.36% since 09/13/24 |
| Low | 18.08 on 10/05/20 | 64.70 on 09/20/24 | 48.78 on 09/18/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 |
| High | 18.17 on 10/09/20 | 75.37 on 09/17/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 |
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | -24.44% since 08/20/24 | +0.88% since 08/20/24 | +2.69% since 08/20/24 | +12.29% since 08/20/24 |
| Low | 18.05 on 09/21/20 | 64.11 on 09/12/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.80 on 08/21/24 |
| High | 18.22 on 09/28/20 | 88.59 on 08/21/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -51.12% since 06/20/24 | +20.39% since 06/20/24 | +8.87% since 06/20/24 | +22.56% since 06/20/24 |
| Low | 9.81 on 08/05/20 | 64.11 on 09/12/24 | 39.35 on 07/05/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 |
| High | 19.65 on 08/31/20 | 138.07 on 06/25/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | -36.27% since 03/20/24 | -4.76% since 03/20/24 | +23.56% since 03/20/24 | +13.46% since 03/20/24 |
| Low | 9.81 on 08/05/20 | 64.11 on 09/12/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 |
| High | 19.65 on 08/31/20 | 170.47 on 05/24/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 26,067,982 | 99,368,440 | 180,215,344 | 104,527,072 |
| Shares Outstanding, K | 101,599 | 383,240 | 2,027,100 | 536,435 | 1,245,853 |
| Annual Sales | 488,540,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | 40,770,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 22,380,000 | 241,000,000 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -49,580,000 | -1,279,000,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 |
| 60-Month Beta | 1.45 | 1.67 | 0.46 | 0.61 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | -3.33 on 08/01/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/03/20 | 11/07/24 | 10/31/24 | 10/29/24 | 11/05/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | N/A | 10/04/24 | 08/16/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 36.31 | 17.90 | 17.85 |